Medler, Terry R.
Kramer, Gwen
Bambina, Shelly
Gunderson, Andrew J.
Alice, Alejandro
Blair, Tiffany
Zebertavage, Lauren
Duhen, Thomas
Duhen, Rebekka
Young, Kristina
Crittenden, Marka R.
Gough, Michael J. http://orcid.org/0000-0002-5575-0074
Funding for this research was provided by:
National Cancer Institute (K22CA251643, R01CA208644, R01CA182311)
Article History
Received: 7 October 2022
Accepted: 13 April 2023
First Online: 18 April 2023
Competing interests
: MJG receives research funding from Bristol Myers Squibb and VIR Biotechnology. KY receives research funding from Bristol Myers Squibb and consulting fees/stock from Synthis Therapeutics. MRC receives consulting fees from Roche. All other authors have no conflicts to declare. Research funding is not directly related to the topic of this manuscript. Funders had no role in the representation of the data or the preparation of the manuscript.